Compare Stocks › ABBV vs TPR

AbbVie Inc. (ABBV) vs Tapestry, Inc. (TPR): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. TPR is undervalued at $116, with an intrinsic value of $200 and a margin of safety of 42%. Of the two, TPR has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
TPR
Tapestry, Inc.
$116.29

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
TPR
  • ★Gross margin of 76.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Tapestry, Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 31.8% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
TPR
  • ⚠FCF yield of 6.1% suggests reasonable valuation assuming continued moderate growth.
  • ⚠High leverage (4.05x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • ⚠Insiders have sold $4.3M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
TPR
Valuation
N/A
Free Cash Flow
$1.40B
N/A
FCF Yield
6.07%
50.67
Trailing P/E
16.00
18.24
Forward P/E
13.08
Quality & Moat
29.08%
ROIC
26.97%
N/A
ROE
197.13%
73.72%
Gross Margin
76.59%
0.60
PEG Ratio
1.66
Balance Sheet Safety
N/A
Net Debt / Equity
4.05
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.39
2.35%
Dividend Yield
1.59%
ABBV: 3Ties: 2TPR: 3
ABBVTPR

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TPR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TPR
$9.45
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.58B
Δ Market Cap
+$14.93B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TPR
42.0% Margin of Safety
Price is 42.0% below estimated fair value
Current Price: $116.29
Fair Value: $200.40
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

TPR

What growth rate is the market pricing in at $116?

+5.0%
Market-Implied Owner Earnings Growth
Standard FCF implies +6.7%

The market implies +5.0% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +6.7%, reflecting ongoing growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
TPR
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TPR
-2.78
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TPR
Insiders 0.4%Institutions 103.0%
No. of Institutional Holders1,541
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
TPR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TPR
2
Sells (3M)
19
Sells (12M)
Total value (12M): $48.44M
KULIKOWSKY DENISE
Officer
$670,329
@ $115.38 · 2026-09-09
CREVOISERAT JOANNE C
Chief Executive Officer
$3.68M
@ $132.47 · 2026-08-19
KAHN TODD LEONARD
Officer
$2.74M
@ $140.02 · 2026-05-26
CREVOISERAT JOANNE C
Chief Executive Officer
$3.69M
@ $132.89 · 2026-05-13
DADLANI MANESH
Officer
$152,149
@ $156.05 · 2026-03-03
CREVOISERAT JOANNE C
Chief Executive Officer
$7.56M
@ $154.87 · 2026-02-18
GRECO THOMAS R
Director
$2.20M
@ $154.44 · 2026-02-17
DADLANI MANESH
Officer
$329,492
@ $153.47 · 2026-02-11
ROE SCOTT A
Chief Operating Officer
$6.76M
@ $152.62 · 2026-02-10
GATES ANNE
Director
$999,327
@ $153.79 · 2026-02-10
KULIKOWSKY DENISE
Officer
$1.43M
@ $155.62 · 2026-02-10
KAHN TODD LEONARD
Officer
$6.03M
@ $151.34 · 2026-02-09
KULIKOWSKY DENISE
Officer
$67,144
@ $115.17 · 2025-12-04
KULIKOWSKY DENISE
Officer
$184,133
@ $110.19 · 2025-11-26
KAHN TODD LEONARD
Officer
$1.11M
@ $107.00 · 2025-11-24
ROE SCOTT A
Chief Operating Officer
$1.97M
@ $104.85 · 2025-11-21
CREVOISERAT JOANNE C
Chief Executive Officer
$3.34M
@ $105.31 · 2025-11-21
KAHN TODD LEONARD
Officer
$2.98M
@ $102.83 · 2025-11-18
HOWARD DAVID E
Officer
$2.57M
@ $102.50 · 2025-11-18
LAU KA MING ALAN
Director
$1.20M
@ $106.19 · 2025-09-11
DADLANI MANESH
Officer
$780,712
@ $99.05 · 2025-08-25
DADLANI MANESH
Officer
$137,260
@ $82.29 · 2025-05-13
KAHN TODD LEONARD
Officer
$3.26M
@ $81.40 · 2025-05-12
KAHN TODD LEONARD
Chief Executive Officer
$3.58M
@ $84.71 · 2025-02-26
KAHN TODD LEONARD
Officer
$681,976
@ $87.59 · 2025-02-21
HOWARD DAVID E
General Counsel
$1.05M
@ $88.00 · 2025-02-20
ROE SCOTT A
Chief Operating Officer
$2.23M
@ $86.56 · 2025-02-20
KAHN TODD LEONARD
Officer
$4.19M
@ $58.68 · 2024-11-25
HOWARD DAVID E
General Counsel
$2.48M
@ $58.95 · 2024-11-22
DADLANI MANESH
Officer
$514,219
@ $57.96 · 2024-11-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TPR
FearGreed
😨Fear(38/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
TPR
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (38)
View ABBV Full AnalysisView TPR Full Analysis

Frequently Asked Questions: ABBV vs TPR

Is AbbVie Inc. or Tapestry, Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, TPR trades at a 42.0% margin of safety (intrinsic value $200 vs. price $116), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Tapestry, Inc.?▼

ABBV scores 82/100 (Wide moat), while TPR scores 77/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. TPR scores 4.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Tapestry, Inc.?▼

ABBV earns 29.1% ROIC versus TPR's 27.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Tapestry, Inc.'s?▼

TPR's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). TPR has raised its dividend for 3 consecutive years.